Medtronic
Update in progressMDT (NYSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Medtronic plc develops, manufactures, and sells device-based medical therapies worldwide for hospitals, clinicians, and patients. Its Cardiovascular Portfolio includes pacemakers, defibrillators, CRT devices, ablation tools, monitors, remote monitoring, valves, stents, PCI products, and related accessories. Neuroscience covers spinal and brain implants, drug infusion, nerve modulation, and Accurian nerve ablation. Medical Surgical includes surgical devices, robotics, gynecology, GI, diagnostics, and monitoring. Diabetes provides insulin pumps, CGMs, sensors, and InPen. HQ: Galway, Ireland.
Company score
- Sentiment
- -0.72
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.02
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -1.51
- Governance
- -2.22
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.91
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.81
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!